Healio: Benefit of radiotherapy for nasopharyngeal carcinoma may vary by time of day Benefit of radiotherapy for nasopharyngeal carcinoma may vary by time of day Adjuvant therapy with camrelizumab significantly improved 3-year event-free survival in patients with locoregionally advanced nasopharyngeal carcinoma compared with observation, according to findings ... Nasopharyngeal carcinoma (NPC), a malignancy that develops in the upper section of the throat behind the nose, occurs in fewer than one person out of 100,000 worldwide each year. Locally advanced ...
EurekAlert!: Landmark study uncovers role of tumor microenvironment in nasopharyngeal carcinoma progression which supports personalized treatment Landmark study uncovers role of tumor microenvironment in nasopharyngeal carcinoma progression which supports personalized treatment EurekAlert!: circTP63-N suppresses the proliferation and metastasis of nasopharyngeal carcinoma via engaging with HSP90AB1 to modulate the YAP1/Hippo signaling pathway circTP63-N suppresses the proliferation and metastasis of nasopharyngeal carcinoma via engaging with HSP90AB1 to modulate the YAP1/Hippo signaling pathway
